Serum ubiquitin levels in patients with nonalcoholic steatohepatitis

Hepato-Gastroenterology

Volumn 50, Issue 51, 2003, Pages 738-741

  Savas, M Cemil ^a,c   Koruk, Mehmet ^a   Pirim, Ibrahim ^b   Yilmaz, Omer ^b   Karakok, Metin ^a   Taysi, Seyithan ^b   Yilmaz, Arif ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Nonalcoholic steatohepatitis; Ubiquitin

Indexed keywords

UBIQUITIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE MARKER; DISEASE SEVERITY; FATTY LIVER; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SERUM;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; HUMANS; LIPID PEROXIDATION; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; UBIQUITIN;

EID: 0038238882     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Day CP: Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 2002; 50:585-588.
2. McCullough AJ: Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002; 34:255-262.
3. Ciechanover A, Scwartz A: Ubiquitin-mediated degradation of cellular proteins in health and disease. Hepatology 2002; 35:3-6.
4. Conaway RC, Brower CS, Conaway JW: Emerging roles of ubiquitin in transcription regulation. Science 2002; 296:1254-1258.
5. Banner BF, Savas L, Zivny L, Tortorelli K, Bonkovsky HL: Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis. Am J Clin Pathol 2000; 114:860-866.
6. Lowe J, Mayer RJ, Landon M: Ubiquitin in neurodegenerative diseases. Brain Pathol 1993; 3:55-65.
7. Askanas V, Serdaroglu P, Engel WK, Alvarez RB: Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body mitosis and oculopharyngeal muscular dystrophy. Neurosci Lett 1991; 130:73-76.
8. Hayashi T, Tanaka J, Kamikubo T, Takada T, Matsuda M: Increase in ubiquitin conjugates dependent on ischemic damage. Brain Res 1993; 620:171-173.
9. Ishibashi Y, Takada K, Joh K, Ohkawa Kaoki T, Matsuda M: Ubiquitin immunoreactivity in human malignant tumours. Br J Cancer 1991; 63:320-322.
10. Akarsu E, Pirim I, Çapoglu I, Deniz O, Akçay G, Ünüvar N: Relationship between electroneurographic changes and serum ubiquitin levels in patients with type 2 diabetes. Diabetes Care 2001; 24:100-103.
11. Kudo T, Iqbal K, Ravid R, Swaab DF, Grundke-Iqbal I: Alzheimer's disease. Correlation of cerebro-spinal fluid and brain ubiquitin levels. Brain Res 1994; 639:1-7.
12. Vyberg M, Leth P: Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease. APMIS Suppl 1991; 23:46-52.
13. Brunt EM, Janney CG, DiBisceglie AM, et al: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467-2474.
14. Takada K, Nasu H, Hibi N, et al: Serum concentrations of free ubiquitin and multiubiquitin chains. Clin Chem 1997; 43:1188-1195.
15. Takagi M, Yamauchi M, Toda G, Takada K, Hirakawa T, Ohkawa K: Serum ubiquitin levels in patients with alcoholic liver disease. Alcohol Clin Exp Res 1999; 23(4 Suppl):76S-80S.